CollPlant Biotechnologies Ltd. (CLGN) vs Lexaria Bioscience Corp. (LEXX)

A side-by-side comparison of CollPlant Biotechnologies Ltd. and Lexaria Bioscience Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CLGN vs LEXX

growth of $100 · dividends reinvested · last 6y
CLGN -97.4% (-45.7%/yr)LEXX -95.9% (-41.2%/yr)LEXX compounded faster over this window
050100150Start $10020222023202420252026$3$4
CLGN LEXX

CLGN vs LEXX: by the numbers

  • •LEXX is the larger company ($5M vs $4M market cap).
  • •Both run net losses; CLGN's is the smaller (-3934.91% vs -3985.58% net margin).
  • •LEXX grew revenue faster over the past five years (12.92% vs -56.28% CAGR).

Metrics side by side

Valuation

MetricCLGNLEXX
P/S ratio13.6224.70
P/B ratio1.471.01

Profitability

MetricCLGNLEXX
Gross margin26.32%100.00%
Operating margin-484.31%-1683.01%
Net margin-3934.91%-3985.58%
ROE-424.89%-163.18%
ROIC-221.32%-175.26%

Growth (annualized)

MetricCLGNLEXX
Revenue CAGR (5Y)-56.28%12.92%
Total return CAGR (5Y)-53.69%-50.86%

Frequently asked

Which has grown faster, CLGN or LEXX?
Over the past five years, LEXX grew revenue faster — CLGN at a -56.28% CAGR versus LEXX at 12.92%.
How have CLGN and LEXX total returns compared?
Over the past 5 years, CLGN delivered -53.69% and LEXX delivered -50.86% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.